Fraudsting lobsterWell caught again in your fraudsting attempt freakin idiot. As I bring on the real facts your lying story is changing. The bottom line is that Avastin got 58.8% PFS at 6 months. This is the benchmark for TLN. That means 12 patients out of 20 with PFS. So to beat that, 4601 is better to be very good. So clearly, the longer does not mean the better. We simply don't know. Today is the last day of the given timeframe for interim results. Brain scans proving the drug is getting there were supposed to be released a long while ago, and they were not. I don't know about results. But for me it looks like a black box. Purely speculative. We have simply no clue to make a guess. It is either you believe or not. But I hope that everybody is realizing that TLN are very far away from anything conclusive. If you still dream of dramatic price rise in the short term. You are dreaming. TLN's management are realistic. They made the tax losses deal because they knew there is still a very very long way to go.